TRUS Destekli Prostat Biyopsisi için Sanal MR/Ultrason Rehberliği

Siemens offers the ArtemisTM solution by Eigen1

TRUS Destekli Prostat Biyopsisi için Sanal MR/Ultrason Rehberliği
 
Bizle İletişime Geçin

With ArtemisTM by Eigen, Siemens Accessories Solutions offers a comprehensive and proven system for integrating reliable multiparametric MRI information into TRUS-guided prostate biopsies.

The key elements for a successful clinical integration of multiparametric MR information into TRUS-assisted prostate biopsies are:

  • Ease of use
  • Standardized integration of multiparametric MRI information
  • Suitability for transrectal and perineal procedures


The ArtemisTM comprises three system components that support the streamlined and efficient workflow needed to integrate multiparametric MRI into TRUS-guided prostate biopsies. With a reported total intervention time of approximately 20 minutes2 it has a clear advantage in terms of intervention compared to targeted prostate biopsies performed under direct MRI guidance.3

 

ArtemisTM – Three System Components for Diagnostic Confidence


Pro FuseTM

Definition of region of interest for interventions based on multiparametric MRI with a comprehensive planning tool

  • Available where needed e.g. in the radiology reading room, at a separate workplace, during an intervention
  • Easy communication of intervention planning data to the ArtemisTM biopsy system

 



ProFuse BXTM

Integration of MR data into TRUS assisted biopsy

  • Quick and easy
  • Takes endorectal coils, bladder filling, and patient position into account


ArtemisTM

Semi-automated TRUS-guided prostate biopsy

  • 3D navigation and real-time control
  • Accelerates biopsy procedures
  • Detailed reporting and management of pathology and clinical history

1The information shown herein refers to products of 3rd party manufacturer’s (ArtemisTM, Eigen) and thus are in their regulatory responsibility. Please contact the 3rd party manufacturer for further information.

2Sonn, G.A. et al.; Targeted Biopsy in the Detection of Prostate Cancer using an Office-Based MR-US Fusion Device; J Urol., 2013 January ;189(1): 86–91. DOI:10.1016/j.juro.2012.08.095

3Overduin, C. et al. MRI-Guided Biopsy for Prostate Cancer Detection: A Systematic Review of Current Clinical Results; Curr Urol. Rep (2013) 14:209–213. DOI 10.1007/s11934-013-0323-z